Provider
QP99-18 New FEP Employee Opioid Prescription Requirements
Program effective Date: Nov 28, 2018
Search Results
Displaying 2461 - 2470 of 4204 results
Provider
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Program effective Date: Aug 21, 2018
Provider
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Program effective Date: Jul 20, 2017
Provider
QP20-17 Searching Eligibility and Benefits
Program effective Date: Aug 08, 2017
Provider
QP68-18 Site of Care Drug Infusion/Injection Program
Program effective Date: Aug 21, 2018
Provider
QP61-18 Availity Authorization Training with Live Demo
Program effective Date: Aug 06, 2018
Provider
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Program effective Date: Aug 21, 2018
Provider
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Program effective Date: Aug 21, 2018
Provider
QP28-17 Notification of Provider Submitted Appeals
Program effective Date: Sep 12, 2017
Provider
QP60R1-18 Update: Change to Call Center for Transportation for MHCP Members
Program effective Date: Sep 14, 2018